ROS-differentiated release of Apelin-13 from hydrogel comprehensively treats myocardial ischemia-reperfusion injury
Penghao Zhen,
No information about this author
Qiaochu Jiang,
No information about this author
Fuchao Yu
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
379, P. 609 - 620
Published: Jan. 24, 2025
Language: Английский
Cardiac Tissue Engineering Using Stimuli‐Responsive Biomaterials for the Targeted Therapy of Myocardial Infarction
Zarin Tasnim Tisha,
No information about this author
Kazi Tasnuva Alam,
No information about this author
Tanvir Ahmed
No information about this author
et al.
MedComm – Biomaterials and Applications,
Journal Year:
2025,
Volume and Issue:
4(1)
Published: March 1, 2025
ABSTRACT
Cardiac
tissue
engineering
presents
a
viable
strategy
for
the
targeted
therapy
of
myocardial
infarction
(MI),
overcoming
limitations
existing
therapies
in
cardiac
repair
and
regeneration.
This
review
explores
potential
stimuli‐responsive
biomaterials
that
engage
with
environment
by
reacting
to
various
environmental
stimuli
including
pH,
temperature,
enzymes,
ultrasound,
reactive
oxygen
species.
These
materials
enable
precise
drug
delivery,
modulate
cellular
responses,
enhance
Biomaterials
such
as
hydrogels,
polymers,
chitosan,
collagen,
alginate
improve
accuracy
effectiveness
localized
delivery
drugs,
stem
cells,
growth
factors,
thus
improving
precision
efficacy
treatments.
The
looks
at
ability
these
mimic
complex
biochemical
mechanical
cues
healthy
myocardium.
challenges
prospects
clinical
applications
are
discussed,
highlighting
their
transformative
while
outcomes
patients
MI.
Language: Английский
Targeting Reactive Oxygen Species for Diagnosis of Various Diseases
Moung Young Lee,
No information about this author
Dong‐Uk Lee,
No information about this author
Dong‐Kug Choi
No information about this author
et al.
Journal of Functional Biomaterials,
Journal Year:
2024,
Volume and Issue:
15(12), P. 378 - 378
Published: Dec. 15, 2024
Reactive
oxygen
species
(ROS)
are
generated
predominantly
during
cellular
respiration
and
play
a
significant
role
in
signaling
within
the
cell
between
cells.
However,
excessive
accumulation
of
ROS
can
lead
to
dysfunction,
disease
progression,
apoptosis
that
organ
dysfunction.
To
overcome
short
half-life
relatively
small
amount
produced,
various
imaging
methods
have
been
developed,
using
both
endogenous
exogenous
means
monitor
settings.
In
this
review,
we
discuss
molecular
mechanisms
underlying
production
explore
materials
could
be
used
detect
overproduction,
including
iron-based
materials,
ROS-responsive
chemical
bond
containing
polymers,
molecule
biomaterials.
We
also
techniques
target
overproduction.
potentials
established
clinical
methods,
such
as
magnetic
resonance
(MRI),
sonographic
imaging,
fluorescence
imaging.
other
photoacoustic
(PAI)
Raman
(RI)
currently
preclinical
stage
discussed.
Finally,
paper
focuses
on
diseases
associated
with
current
future
applications
ROS-targeted
While
most
widely
condition
is
cardiovascular
diseases,
its
potential
extends
into
non-cardiovascular
conditions,
neurovascular,
neurodegenerative,
ROS-associated
cancers,
skin
aging,
acute
kidney
injury,
inflammatory
arthritis.
Language: Английский